The future of gene-targeted therapy for hereditary tyrosinemia type 1 as a lead indication among the inborn errors of metabolism
Whitney S. Thompson(Mayo Clinic), Joseph B. Lillegard(Mayo Clinic), Robert A. Kaiser(Mayo Clinic in Florida), Gourish Mondal(Mayo Clinic in Florida), Caitlin J. VanLith(Mayo Clinic in Florida)
Cited by 14
Related Papers
Inherited deficiency of the Mac-1, LFA-1, p150,95 glycoprotein family and its molecular basis.
|The Journal of Experimental Medicine|1984|483
IL-21 production by CD4+ effector T cells and frequency of circulating follicular helper T cells are increased in type 1 diabetes patients
|Diabetologia|2015|144
Cells with Treg-specific FOXP3 demethylation but low CD25 are prevalent in autoimmunity
|Journal of Autoimmunity|2017|92
Multi-parametric flow cytometric and genetic investigation of the peripheral B cell compartment in human type 1 diabetes
|Clinical & Experimental Immunology|2014|57
Simian Virus 40 (SV40)-Specific Isoelectric Point-4.7-94,000-<italic>M</italic><sub>r</sub> Membrane Glycoprotein: Major Peptide Homology Exhibited With the Nuclear and Membrane-Associated 94,000-<italic>M</italic><sub>r</sub> SV40 T-Antigen in Hamsters<xref ref-type="fn" rid="FN2">2</xref><xref ref-type="fn" rid="FN3">3</xref>
|JNCI Journal of the National Cancer Institute|1982|25